1. Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

   • Enrico Fabris
   • Abi Selvarajah
   • Arnoud van’t Hof

   Review Article Open access 22 March 2022 Pages: 463 - 474

   

2. Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies

   • Jordan L. Lacoste
   • Thomas W. Szymanski
   • Arshad Jahangir

   Review Article 30 March 2022 Pages: 475 - 496

   

3. The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review

   • Jay M. Edelberg
   • Amy J. Sehnert
   • Robert McDowell

   Review Article Open access 18 April 2022 Pages: 497 - 510

   

4. Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis

   • Boon-Hao Suah
   • Zhi-Yan Lee
   • Ching-Hui Sia

   Systematic Review 16 March 2022 Pages: 511 - 521

   

5. The Effect of Vasopressin and Methylprednisolone on Return of Spontaneous Circulation in Patients with In-Hospital Cardiac Arrest: A Systematic Review and Meta-analysis of Randomized Controlled Trials

   • Basel Abdelazeem
   • Ahmed K. Awad
   • Arvind Kunadi

   Systematic Review 22 March 2022 Pages: 523 - 533

   

6. Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective Study

   • Mohammad Abumayyaleh
   • Jonathan Demmer
   • Ibrahim Akin

   Original Research Article Open access 30 March 2022 Pages: 535 - 544

   

7. Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis

   • Nihar R. Desai
   • Caresse Campbell
   • Joaquim Cristino

   Original Research Article Open access 21 May 2022 Pages: 545 - 556

   

8. Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study

   • Langjing Huang
   • Zhihua Yu
   • Xiaoke Shang

   Original Research Article 18 June 2022 Pages: 557 - 565

   

9. Contemporary Trends in the Use of and Expenditures on Digoxin in the United States

   • Abdullah A. Alahmed
   • Julie C. Lauffenburger
   • Leo F. Buckley

   Original Research Article 24 June 2022 Pages: 567 - 575

   

10. Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction

    • Rungroj Krittayaphong
    • Unchalee Permsuwan

    Original Research Article 07 July 2022 Pages: 577 - 590